<DOC>
	<DOCNO>NCT01860781</DOCNO>
	<brief_summary>The purpose study evaluation effectiveness paliperidone palmitate within three different group schizophrenia patient .</brief_summary>
	<brief_title>The Effect Paliperidone Palmitate Schizophrenia</brief_title>
	<detailed_description>In study , investigator go examine effectiveness paliperidone palmitate change antipsychotic . This study design Prospective Naturalistic Case Series Study . The effectiveness paliperidone would compare within three different group schizophrenia . Investigators would also assess safety 24 week follow period .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<criteria>Age : 18 ~ 65 Patient schizophrenia accord DSMIV criterion Patient sign informed consent , well understood objective procedure study . PANSSS total score &lt; 120 Score disorganize think , paranoia hallucinatory behavior , abnormal tbought contest &lt; 16 three different group ( antipsychotic refractory schizophrenia patitents : CGI &gt; 4 chronic akathisia : DIEPSS overall severity &gt; 1 , least 1 month lasting symptom poor compliance schizophrenia : CRS &lt; 3 ) Competent patient manage answer questionnaire . In case female childbearing age , consent use appropriate contraceptive method ( oral pill , contraceptive injection , intrauterine device , double barrier method contraceptive patch ) entire duration study . No history antipsychotic prescription History NMS ( Neuroleptic malignant syndrome ) Allergic reaction hypersensitive reaction risperidone paliperidone ER clozapine medication within 1 month screen SSRI , MAOI , TCA medication within 2 month Lithium , valproic acid , carbamazepine , topiramate , lamotrigine medication start within 2 month patient suppose impossible participate study due clinical risk suicide aggressive behavior base clinician 's opinion current previous history drug depedence accord DSMIV Pregnant breastfeed female patient Significant biochemical hematological abnormality abnormal finding urinalysis , base clinician 's opinion history cardiac disease , relate QT prolongation ( sick sinus , complete AV block , CHF , ventricular tachycardia , hypokalemia hypocalcemia ) History participate investigational drug trial within 1month prior screen Investigator employee clinical trial center , personnel relate investigator trial center study , family employee investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Injection</keyword>
	<keyword>Switch</keyword>
	<keyword>Paliperidone</keyword>
	<keyword>refractory , chronic akathisia , poor complianc</keyword>
</DOC>